Sheba Medical Centre has been ranked as one of the top hospitals in the world for six years in a row. As a truly massive facility, Sheba provides innovative treatments, research and procedures that are not available anywhere else in the world. Choosing Sheba means having access to the best medical technology worldwide, including experimental treatments.
Sheba Medical Centre is the home of the Ella Lemelbaum Institute for Immuno-Oncology, a world class facility for melanoma treatment. Here, melanoma patients receive tailor-made medicine in the fight against melanoma. Our multidisciplinary team of dermatologists, surgical oncologists, medical oncologists, radiation oncologists, and support staff takes a holistic approach to determine the best course of action.
To that end the Ella Institute works at conjunction with some of the leading melanoma treatment centres around the globe, including the National Institutes of Health (NIH) in the United States.
We are proud to provide the absolute latest in melanoma treatment, including advanced imunnotherapy techniques and the opportunity to participate in many ongoing clinical studies.
Unique treatments for our patients:
1. Sheba Medical Centre is a leader in tumour infiltrating lymphocytes (TIL) immunotherapy for metastatic melanoma.
This treatment uses the patient's own immune system lymphocytes (white blood cells). These lymphocytes will attack tumour cells, but in metastatic melanoma patients, the lymphocytes are not strong enough to make much progress against the tumour. This is where TIL comes in.
After removing part of the tumour, healthcare personnel isolate the lymphocytes. The lymphocytes are grown to very large numbers in our advanced laboratory. Then the lymphocytes are reintroduced into the patient's body, where they hunt down tumour cells. This groundbreaking technique provides hope for many patients with even advanced melanoma.
2. Fecal microbiota transsplant
This treatment was developed under the assumption that the bacteria found in the digestive tract work closely with the immune system. A change in the flora of the bacteria has an effect on many health conditions, including the course of the oncological disease. It was suggested that if the immunotherapy treatment doesn't work, a change in the composition of the bacteria would make the patient non-resistant, i.e. respond to immunotherapy. In this treatment, bacteria are taken from melanoma patients who have responded to the treatment and introduced to unresponsive patients. The patient's flora changes and he begins to respond to immunotherapy.